Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
NCT ID: NCT00532506
Last Updated: 2008-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SK-0403
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable diet program for at least 8 weeks
* Criteria for HbA1c are met
Exclusion Criteria
* Patients treated with other antidiabetic drugs or Insulin
20 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanwa Kagaku Kenkyusho Co., Ltd.
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ryuzo Kawamori, M.D.
Role: STUDY_CHAIR
Juntendo University School of Medicine, Dept. of Endocrinology and Metabolism
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fukuoka, , Japan
Gifu, , Japan
Gunma, , Japan
Hokkaido, , Japan
Ibaraki, , Japan
Kanagawa, , Japan
Kumamoto, , Japan
Okinawa, , Japan
Ōita, , Japan
Tokyo, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DP1001
Identifier Type: -
Identifier Source: org_study_id